Education
About Us
Working with TipRanks
Follow Us
CAMP4 Therapeutics Corporation (CAMP)
:CAMP
RESEARCH TOOLSreports
| Mar 23 | Mar 22 | Mar 21 | Mar 20 | Mar 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 294.95M | $ 295.84M | $ 308.59M | $ 366.11M | $ 363.80M |
| Gross Profit | $ 109.01M | $ 121.89M | $ 122.41M | $ 143.30M | $ 147.76M |
| Operating Income | $ -21.48M | $ -15.31M | $ -3.87M | $ -16.77M | $ 19.70M |
| EBITDA | $ 276.00K | $ 7.49M | $ 18.13M | $ 15.22M | $ 47.05M |
| Net Income | $ -32.49M | $ -31.15M | $ -21.16M | $ -78.77M | $ 18.40M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 41.93M | $ 79.22M | $ 94.62M | $ 107.40M | $ 274.01M |
| Total Assets | $ 380.12M | $ 391.58M | $ 433.81M | $ 495.81M | $ 603.63M |
| Total Debt | $ 240.44M | $ 205.67M | $ 203.53M | $ 234.49M | $ 275.90M |
| Net Debt | $ 198.51M | $ 126.45M | $ 108.91M | $ 127.08M | $ 19.41M |
| Total Liabilities | $ 365.81M | $ 316.18M | $ 338.72M | $ 357.89M | $ 397.97M |
| Stockholders' Equity | $ 14.31M | $ 75.40M | $ 95.08M | $ 137.92M | $ 205.65M |
| Cash Flow | |||||
| Free Cash Flow | $ -34.03M | $ -17.52M | $ 17.23M | $ -10.65M | $ 35.73M |
| Operating Cash Flow | $ -22.93M | $ -4.22M | $ 28.59M | $ 11.54M | $ 47.74M |
| Investing Cash Flow | $ -11.10M | $ -7.58M | $ -13.69M | $ -65.70M | $ -21.79M |
| Financing Cash Flow | $ -909.00K | $ -2.64M | $ -27.32M | $ -94.82M | $ 98.50M |